CSIMarket
 


Xoma Corporation  (XOMA)
Other Ticker:  
 

Cumulative Xoma's Leverage Ratio for Trailing Twelve Months Period

XOMA's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

XOMA Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth -28.46 % -18.69 % -18.4 % -18.15 % -12.59 %
Y / Y Total Liabilities Growth 789.42 % 14.7 % -19.36 % -0.51 % -33.7 %
Leverage Ratio for Trailing Twelve Months Period 0.47 0.15 0.14 0.14 0.13
Total Ranking # 539 # 290 # 292 # 325 # 368
Seq. Equity Growth -16.27 % -3.78 % -3.84 % -7.65 % -4.84 %
Seq. Total Liabilities Growth 702.98 % 16.69 % -18.82 % 16.92 % 3.56 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Due to net new borrowings of 702.98%, Leverage Ratio for Trailing Twelve Months Period improved to 0.47, below Xoma's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 149 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Xoma. While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are XOMA's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 150
Sector # 342
S&P 500 # 1525


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
9.08 1.95 0.13
(Sep 30 2018)   (Dec 31 2022)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Viatris Inc   1.29 
Merck and Co Inc   1.28 
Sigilon Therapeutics Inc   1.26 
Cerevel Therapeutics Holdings Inc   1.26 
Sonoma Pharmaceuticals Inc   1.26 
Johnson and Johnson  1.25 
Nektar Therapeutics  1.24 
Ani Pharmaceuticals Inc  1.23 
Prestige Consumer Healthcare Inc   1.20 
Takeda Pharmaceutical Company Limited  1.20 
Arvinas Inc   1.19 
Earth Science Tech Inc   1.19 
Biovie Inc   1.19 
Perrigo Company Plc  1.17 
Kintara Therapeutics Inc   1.17 
Lifevantage Corp  1.17 
Pfizer Inc  1.16 
Verastem inc   1.16 
180 Life Sciences Corp  1.16 
Rani Therapeutics Holdings Inc   1.11 
Coya Therapeutics Inc   1.11 
Macrogenics Inc   1.11 
Milestone Pharmaceuticals inc   1.10 
Novartis Ag  1.09 
Can fite Biopharma Ltd   1.07 
Atreca inc   1.07 
Royalty Pharma Plc  1.07 
Elanco Animal Health Inc  1.07 
Eyenovia inc   1.06 
Cyclacel Pharmaceuticals Inc   1.06 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com